These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 27442028)

  • 1. Prognostic value of right ventricular ejection/filling parameters in IPAH using cardiac magnetic resonance: A prospective pilot study.
    Li W; Yang T; Zhang Y; Gu Q; Liu ZH; Ni XH; Luo Q; Xiong CM; He JG
    Respirology; 2017 Jan; 22(1):172-178. PubMed ID: 27442028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive capabilities of a novel cardiovascular magnetic resonance derived marker of cardiopulmonary reserve on established prognostic surrogate markers in patients with pulmonary vascular disease: results of a longitudinal pilot study.
    Baillie TJ; Sidharta S; Steele PM; Worthley SG; Willoughby S; Teo K; Sanders P; Nicholls SJ; Worthley MI
    J Cardiovasc Magn Reson; 2017 Jan; 19(1):3. PubMed ID: 28065166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The right heart in heart failure with preserved ejection fraction: insights from cardiac magnetic resonance imaging and invasive haemodynamics.
    Aschauer S; Kammerlander AA; Zotter-Tufaro C; Ristl R; Pfaffenberger S; Bachmann A; Duca F; Marzluf BA; Bonderman D; Mascherbauer J
    Eur J Heart Fail; 2016 Jan; 18(1):71-80. PubMed ID: 26449727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tricuspid regurgitation duration correlates with cardiovascular magnetic resonance-derived right ventricular ejection fraction and predict prognosis in patients with pulmonary arterial hypertension.
    Cho IJ; Oh J; Chang HJ; Park J; Kang KW; Kim YJ; Choi BW; Shin S; Shim CY; Hong GR; Ha JW; Chung N
    Eur Heart J Cardiovasc Imaging; 2014 Jan; 15(1):18-23. PubMed ID: 23704751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right ventricular concentric hypertrophy and clinical worsening in idiopathic pulmonary arterial hypertension.
    Badagliacca R; Poscia R; Pezzuto B; Papa S; Pesce F; Manzi G; Giannetta E; Raineri C; Schina M; Sciomer S; Parola D; Francone M; Carbone I; Fedele F; Vizza CD
    J Heart Lung Transplant; 2016 Nov; 35(11):1321-1329. PubMed ID: 27241861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right ventricular remodeling in idiopathic pulmonary arterial hypertension: adaptive versus maladaptive morphology.
    Badagliacca R; Poscia R; Pezzuto B; Nocioni M; Mezzapesa M; Francone M; Giannetta E; Papa S; Gambardella C; Sciomer S; Volterrani M; Fedele F; Dario Vizza C
    J Heart Lung Transplant; 2015 Mar; 34(3):395-403. PubMed ID: 25499139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of Pulmonary Transit Time by Cardiac Magnetic Resonance on Mortality and Heart Failure Hospitalization in Patients With Advanced Heart Failure and Reduced Ejection Fraction.
    Houard L; Amzulescu MS; Colin G; Langet H; Militaru S; Rousseau MF; Ahn SA; Vanoverschelde JJ; Pouleur AC; Gerber BL
    Circ Cardiovasc Imaging; 2021 Jan; 14(1):e011680. PubMed ID: 33438438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac magnetic resonance-derived right ventricular outflow tract systolic flow acceleration: a novel index of right ventricular function and prognosis in patients with pulmonary arterial hypertension.
    Kang KW; Chang HJ; Yoo YP; Yoon HS; Kim YJ; Choi BW; Shim CY; Ha J; Chung N
    Int J Cardiovasc Imaging; 2013 Dec; 29(8):1759-67. PubMed ID: 23861020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of cardiac magnetic resonance imaging for idiopathic pulmonary arterial hypertension before initiating intravenous prostacyclin therapy.
    Yamada Y; Okuda S; Kataoka M; Tanimoto A; Tamura Y; Abe T; Okamura T; Fukuda K; Satoh T; Kuribayashi S
    Circ J; 2012; 76(7):1737-43. PubMed ID: 22498565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of right ventricle in pulmonary arterial hypertension with three-dimensional echocardiography and cardiovascular magnetic resonance.
    Lattanzio M; Scelsi L; Golino M; Lattuada M; Raineri C; Turco A; Giuntini C; Ceriani F; Curti M; Bonelli A; Piacentino F; Venturini M; Ghiringhelli S; Morandi F; De Ponti R; Ghio S
    J Cardiovasc Med (Hagerstown); 2021 Dec; 22(12):929-936. PubMed ID: 34482325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated plasma YKL-40 as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension.
    Chen G; Yang T; Gu Q; Ni XH; Zhao ZH; Ye J; Meng XM; Liu ZH; He JG; Xiong CM
    Respirology; 2014 May; 19(4):608-15. PubMed ID: 24689969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prognostic Value of 18F-FDG Uptake Ratio Between the Right and Left Ventricles in Idiopathic Pulmonary Arterial Hypertension.
    Li W; Wang L; Xiong CM; Yang T; Zhang Y; Gu Q; Yang Y; Ni XH; Liu ZH; Fang W; He JG
    Clin Nucl Med; 2015 Nov; 40(11):859-63. PubMed ID: 26359560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right ventricular involvement evaluated by cardiac magnetic resonance imaging predicts mortality in patients with light chain amyloidosis.
    Wan K; Sun J; Han Y; Luo Y; Liu H; Yang D; Cheng W; Zhang Q; Zeng Z; Chen Y
    Heart Vessels; 2018 Feb; 33(2):170-179. PubMed ID: 28840397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.
    Fijalkowska A; Kurzyna M; Torbicki A; Szewczyk G; Florczyk M; Pruszczyk P; Szturmowicz M
    Chest; 2006 May; 129(5):1313-21. PubMed ID: 16685024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right ventricular dyssynchrony in idiopathic pulmonary arterial hypertension: determinants and impact on pump function.
    Badagliacca R; Poscia R; Pezzuto B; Papa S; Gambardella C; Francone M; Mezzapesa M; Nocioni M; Nona A; Rosati R; Sciomer S; Fedele F; Dario Vizza C
    J Heart Lung Transplant; 2015 Mar; 34(3):381-9. PubMed ID: 25087105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive methods for estimating mPAP in COPD using cardiovascular magnetic resonance imaging.
    Johns CS; Rajaram S; Capener DA; Oram C; Elliot C; Condliffe R; Kiely DG; Wild JM; Swift AJ
    Eur Radiol; 2018 Apr; 28(4):1438-1448. PubMed ID: 29147768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension.
    Freed BH; Gomberg-Maitland M; Chandra S; Mor-Avi V; Rich S; Archer SL; Jamison EB; Lang RM; Patel AR
    J Cardiovasc Magn Reson; 2012 Feb; 14(1):11. PubMed ID: 22296860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extent of RV dysfunction and myocardial infarction assessed by CMR are independent outcome predictors early after STEMI treated with primary angioplasty.
    Miszalski-Jamka T; Klimeczek P; Tomala M; Krupiński M; Zawadowski G; Noelting J; Lada M; Sip K; Banyś R; Mazur W; Kereiakes DJ; Zmudka K; Pasowicz M
    JACC Cardiovasc Imaging; 2010 Dec; 3(12):1237-46. PubMed ID: 21163452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CMR-based heart deformation analysis for quantification of hemodynamics and right ventricular dysfunction in patients with CTEPH.
    Tao X; Liu M; Liu W; Xie W; Wan J; Zhai Z; Wang C
    Clin Respir J; 2020 Mar; 14(3):277-284. PubMed ID: 31814279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood urea nitrogen to serum albumin ratio as a new indicator of disease severity and prognosis in idiopathic pulmonary artery hypertension.
    Zhang S; Gao L; Zhao Z; Zhao Q; Yang T; Zeng Q; Zhang Y; Li X; Huang Z; Duan A; Luo Q; Liu Z
    Respir Med; 2024 Jun; 227():107643. PubMed ID: 38657739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.